Purification and characterization of dihydrofolate reductase from Mycobacterium phlei
- PMID: 3741386
- PMCID: PMC1146682
- DOI: 10.1042/bj2350301
Purification and characterization of dihydrofolate reductase from Mycobacterium phlei
Abstract
The dihydrofolate reductase from Mycobacterium phlei was purified and characterized; it has an Mr of 15 000 and a pI of 4.8. It is competitively inhibited by both methotrexate and trimethoprim, although the affinity is less than for other bacterial dihydrofolate reductases.
Similar articles
-
The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.Eur J Biochem. 1976 Jan 15;61(2):597-603. doi: 10.1111/j.1432-1033.1976.tb10055.x. Eur J Biochem. 1976. PMID: 2472
-
Purification and properties of dihydrofolate reductase from cultured mammalian cells.Biochem J. 1973 Jun;133(2):349-56. doi: 10.1042/bj1330349. Biochem J. 1973. PMID: 4723779 Free PMC article.
-
Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim.J Biol Chem. 1988 Sep 5;263(25):12500-8. J Biol Chem. 1988. PMID: 3045118
-
Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.J Chemother. 1995 Jun;7(3):221-3. doi: 10.1179/joc.1995.7.3.221. J Chemother. 1995. PMID: 7562018 Review.
-
Regulation of dihydrofolate reductase and other folate-requiring enzymes.Adv Enzyme Regul. 1968;6:335-49. doi: 10.1016/0065-2571(68)90021-6. Adv Enzyme Regul. 1968. PMID: 4888607 Review. No abstract available.
Cited by
-
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11. Clin Microbiol Rev. 2012. PMID: 22763637 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous